TMCI
TREACE MEDICAL CONCEPTS, INC.Company Information
- Company Name
- TREACE MEDICAL CONCEPTS, INC.
- CIK
- CIK0001630627
- Category
- Accelerated filer
- Ticker: Exchange
- TMCI: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- TMCI
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-08-24
- Last sale
- 2025-03-17
- Shares purchased (TTM)
- 193,843
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 31,023,698
- Shares outstanding
- 65,049,844
- Ownership
- 47.69%
Earnings Market Reaction
- Filing date
- 2026-08-07
- Price on filing date
- —
- 1-month reaction
- -2.31%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 13 | 10 | 11 | 8 | 8 | 13 | 11 | 12 | 18 | 9 | 13 | 7 | ||||||
| Marketable Securities Current | 33 | 42 | 38 | 50 | 61 | 63 | 64 | 71 | 77 | 101 | 110 | 115 | ||||||
| Accounts Receivable Net Current | 29 | 30 | 42 | 33 | 30 | 31 | 41 | 24 | 26 | 30 | 38 | 25 | ||||||
| Inventory Net | 40 | 36 | 36 | 41 | 42 | 38 | 39 | 44 | 41 | 36 | 29 | 29 | ||||||
| Prepaid Expense And Other Assets Current | 7 | 5 | 6 | 6 | 6 | 4 | 6 | 7 | 10 | 11 | 8 | 11 | ||||||
| Assets Current | 120 | 123 | 132 | 138 | 148 | 149 | 161 | 158 | 172 | 187 | 198 | 187 | ||||||
| Property Plant And Equipment Net | 32 | 32 | 30 | 30 | 30 | 27 | 26 | 25 | 24 | 25 | 22 | 22 | ||||||
| Intangible Assets Net Excluding Goodwill | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | ||||||
| Goodwill | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | ||||||
| Operating Lease Right Of Use Asset | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | ||||||
| Other Assets Noncurrent | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 181 | 184 | 191 | 197 | 206 | 206 | 217 | 213 | 226 | 243 | 252 | 240 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 16 | 14 | 7 | 16 | 20 | 13 | 11 | 19 | 18 | 21 | 12 | 9 | ||||||
| Accrued Liabilities Current | 6 | 6 | 6 | 7 | 6 | 6 | 7 | 8 | 14 | 15 | 10 | 9 | ||||||
| Employee Related Liabilities Current | 8 | 6 | 6 | 7 | 7 | 5 | 7 | 6 | 6 | 4 | 8 | 5 | ||||||
| Liabilities Current | 41 | 34 | 31 | 41 | 42 | 33 | 35 | 38 | 44 | 47 | 45 | 33 | ||||||
| Long Term Debt Noncurrent | 56 | 56 | 56 | 54 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | ||||||
| Operating Lease Liability Noncurrent | 13 | 14 | 14 | 13 | 13 | 14 | 16 | 16 | 16 | 16 | 16 | 16 | ||||||
| Other Liabilities Noncurrent | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 113 | 107 | 103 | 107 | 109 | 101 | 104 | 108 | 114 | 116 | 114 | 103 | ||||||
| Commitments And Contingencies | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 352 | 345 | 337 | 330 | 322 | 312 | 303 | 294 | 286 | 279 | 272 | 266 | ||||||
| Retained Earnings Accumulated Deficit | -283 | -267 | -249 | -240 | -223 | -206 | -190 | -189 | -174 | -153 | -134 | -128 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | ||||||
| Treasury Stock Value | -1 | -1 | -1 | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | - | ||||||
| Stockholders Equity | 68 | 77 | 87 | 89 | 98 | 105 | 113 | 105 | 112 | 126 | 138 | 138 | ||||||
| Liabilities And Stockholders Equity | 181 | 184 | 191 | 197 | 206 | 206 | 217 | 213 | 226 | 243 | 252 | 240 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Finite Lived Intangible Assets Accumulated Amortization | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | ||||||
| Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net | - | - | 4 | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Receivable Allowance For Credit Loss Noncurrent | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Outstanding | - | - | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 65 | 65 | 64 | 64 | 63 | 63 | 62 | 62 | 62 | 62 | 62 | 62 | ||||||
| Shares Outstanding | - | - | - | - | - | - | - | 62 | 62 | 62 | 62 | 62 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialTREACE MEDICAL CONCEPTS, INC. (TMCI) — SEC Financial Statements & Analysis
TREACE MEDICAL CONCEPTS, INC. (TMCI) is a surgical & medical instruments & apparatus company, incorporated in FL. TREACE MEDICAL CONCEPTS, INC. trades on Nasdaq as: TMCI. TREACE MEDICAL CONCEPTS, INC. (TMCI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, TREACE MEDICAL CONCEPTS, INC. carries a market cap of $258.90M, a P/E ratio of -4.35x, a P/B ratio of 3.82x, a P/S ratio of 1.26x, an enterprise value of $302.33M, and an EV/EBITDA multiple of -6.67x. On profitability, it posts a gross margin of 79.45%, an operating margin of -26.17%, a net margin of -28.99%, a Return on Equity (ROE) of -71.99%, a Return on Assets (ROA) of -30.72%, and a Return on Invested Capital (ROIC) of -40.92%. Per share, it reports EPS of $-0.91, diluted EPS of $-0.91, free cash flow per share of $-0.39, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -3.95% year-over-year, net income growth of 21.01% year-over-year, and EPS growth of 17.21% year-over-year. On the balance sheet, it maintains a current ratio of 2.90x, a quick ratio of 1.79x, working capital of $78.96M, a debt-to-equity ratio of 1.67x, a debt ratio of 0.63, an interest coverage ratio of -9.23x, free cash flow of $-25.05M (TTM), and net debt of $43.43M. Figures sourced from SEC EDGAR.
- Market Cap
- $258.90M
- P/E TTM
- -4.35x
- EPS TTM
- $-0.91
- P/B TTM
- 3.82x
- ROE TTM
- -71.99%
- ROA TTM
- -30.72%
- Debt To Equity
- 1.67x
- Free Cash Flow TTM
- $-25.05M
- Net Revenue TTM Growth 1Y
- -3.95%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is TREACE MEDICAL CONCEPTS, INC. in?
TREACE MEDICAL CONCEPTS, INC. (TMCI) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does TMCI trade on?
TREACE MEDICAL CONCEPTS, INC. (TMCI) trades on the Nasdaq.
Where is TREACE MEDICAL CONCEPTS, INC. incorporated?
TREACE MEDICAL CONCEPTS, INC. is incorporated in FL.
When was TREACE MEDICAL CONCEPTS, INC. (TMCI)'s most recent SEC filing?
TREACE MEDICAL CONCEPTS, INC. (TMCI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07.
What is TMCI's market cap?
TREACE MEDICAL CONCEPTS, INC. (TMCI) has a market capitalization of $258.90M as of 2026-06-30.
What is TMCI's EPS (earnings per share)?
TREACE MEDICAL CONCEPTS, INC. (TMCI)'s trailing twelve month EPS is $-0.91 as of 2026-06-30.
What is TMCI's ROE (return on equity)?
TREACE MEDICAL CONCEPTS, INC. (TMCI)'s trailing twelve month Return on Equity (ROE) is -71.99% as of 2026-06-30.
What is TMCI's ROA (return on assets)?
TREACE MEDICAL CONCEPTS, INC. (TMCI)'s trailing twelve month Return on Assets (ROA) is -30.72% as of 2026-06-30.
What is TMCI's ROIC (return on invested capital)?
TREACE MEDICAL CONCEPTS, INC. (TMCI)'s trailing twelve month Return on Invested Capital (ROIC) is -40.92% as of 2026-06-30.
What is TMCI's EV/EBITDA?
TREACE MEDICAL CONCEPTS, INC. (TMCI)'s trailing twelve month EV/EBITDA is -6.67x as of 2026-06-30.